abstract |
The present invention provides a compound of formula 1 used as a JAK inhibitor Or its pharmaceutically acceptable salts. The invention also provides crystalline forms of the compound, pharmaceutical compositions containing the compound, methods of using the compound to treat diseases suitable for JAK inhibitors, and methods and intermediates suitable for preparing the compound. |